NBS3OMD22NCT07877714
Newborn Screening and Early Diagnosis of AADC Deficiency in the Ligurian Population
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Development of an Analytical and Post-Analytical Newborn Screening Protocol for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D)
Timeframe: Two years
Incidence of Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) in the Neonatal Population of Liguria, Italy
Timeframe: Two years.
Secondary (2)
Establishment of Neonatal 3-O-Methyldopa (3-OMD) Reference Values and Screening Cut-off Values
Development of Second-Tier and Confirmatory Biochemical Testing Methods for AADC-D
Sites
10 sites in 1 country